19 May 2013
Keywords: Pfizer, Biocad, Factor VIII, Hemophilia, Pharm-sintez, Cancer drug manufacturing, Russia
Article | 26 June 2012
US drug behemoth Pfizer (NYSE: PFE) is finalizing confidions for the transfer of a license for the production of Factor ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 June 2012
17 May 2013
© 2013 thepharmaletter.com